Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
The latest update is out from Immunovia AB ( (SE:IMMNOV) ).
The annual general meeting of Immunovia AB on May 14, 2025, resulted in several key resolutions, including the adoption of financial statements and the decision to carry forward available funds without issuing dividends. The meeting also saw the re-election and election of board members, approval of board fees, and the appointment of a new auditor. Additionally, the meeting approved an employee option program aimed at attracting and retaining key personnel, which is expected to enhance shareholder value.
More about Immunovia AB
Average Trading Volume: 3,934,391
Current Market Cap: SEK118.1M
For an in-depth examination of IMMNOV stock, go to TipRanks’ Stock Analysis page.